Home › Funds › Meridiem Capital Partners LP › CRL
Meridiem Capital Partners LP position in CRL
CHARLES RIV LABS INTL INC · Health Care
Meridiem Capital Partners LP reported holding 246,979 shares of CRL (CHARLES RIV LABS INTL INC) in its Q2 2026 13F filing — a position valued at US$56.0M, representing 2.58% of its reported portfolio and ranking #8 among its reported holdings. Meridiem Capital Partners LP has disclosed CRL holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Meridiem Capital Partners LP's CRL position evolved
Meridiem Capital Partners LP first disclosed a stake in CRL in Q2 2025 at 120,034 shares (US$18.2M). The position peaked in Q1 2026 at 362,098 shares, worth US$62.5M. Across 5 filings, Meridiem Capital Partners LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 246,979 shares valued at US$56.0M — a reduction of -115,119 shares quarter over quarter.. Notable position changes include a 41% trim in Q3 2025 (shares rose 27% over the following quarter), a 89% increase in Q4 2025 (shares fell 14% over the following quarter), a 172% increase in Q1 2026 (shares rose 31% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 120.03K | $18.21M | New |
| Q3 2025 | 70.47K | $11.03M | Reduce |
| Q4 2025 | 132.88K | $26.51M | Add |
| Q1 2026 | 362.10K | $62.46M | Add |
| Q2 2026 | 246.98K | $56.01M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRL and 13F data
CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 30 other funds we track also report a position in CRL — the largest reported positions include Allspring Global Investments Holdings, LLC (US$436.5M), ARIEL INVESTMENTS, LLC (US$341.6M), EARNEST PARTNERS LLC (US$254.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRL
- Allspring Global Investments Holdings, LLC 1.91M sh · $436.47M · Q2 2026
- ARIEL INVESTMENTS, LLC 1.51M sh · $341.59M · Q2 2026
- EARNEST PARTNERS LLC 1.12M sh · $254.01M · Q2 2026
- COOKE & BIELER LP 755.63K sh · $171.37M · Q2 2026
More on Meridiem Capital Partners LP
FAQ
How long has Meridiem Capital Partners LP held CRL?
Meridiem Capital Partners LP has disclosed CRL holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Meridiem Capital Partners LP's current position in CRL?
As of Q2 2026, Meridiem Capital Partners LP holds 246.98K shares of CRL (CHARLES RIV LABS INTL INC), valued at $56.01M, representing 2.58% of its reported portfolio and ranking #8.
Has Meridiem Capital Partners LP been buying or selling CRL?
In the latest 13F filing (Q2 2026), Meridiem Capital Partners LP reduced its position in CRL. The position peaked in Q1 2026 at 362.10K shares.
Which other funds hold CRL?
Other major institutional holders of CRL include Allspring Global Investments Holdings, LLC, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.